表紙
市場調查報告書

乾眼症症候群治療藥的全球市場: 各產品類型,各流通管道,各地區的市場規模,佔有率,展望,機會分析:2020年∼2027年

Dry Eye Syndrome Treatment Market, by Product Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 948416
出版日期 內容資訊 英文 187 Pages
商品交期: 2-3個工作天內
價格
乾眼症症候群治療藥的全球市場: 各產品類型,各流通管道,各地區的市場規模,佔有率,展望,機會分析:2020年∼2027年 Dry Eye Syndrome Treatment Market, by Product Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月07日內容資訊: 英文 187 Pages
簡介

乾眼症症候群(DES),又稱乾性角膜炎或角膜乾燥症,伴隨眼球表面的損傷,淚液薄膜的不穩定性,視覺障礙等症狀。由於現在新的乾眼症治療藥投入市場,有許多核准申請中的產品,預計今後市場將踏實持續成長。

本報告提供全球金屬奈米粒子和金屬氧化物奈米粒子的市場調查,市場力學和法規,新型冠狀病毒感染疾病(COVID-19)大流行的影響,各產品類型,各用途,各地區的分析,競爭情形與企業簡介等資訊。

目錄

第1章 調查的目的與前提

第2章 市場展望

  • 報告概要
  • 市場定義和範圍
  • 摘要整理
  • 市場區隔: 各產品類型
  • 市場區隔:各流通管道
  • 市場區隔:各地區
    • 市場機會藍圖

第3章 市場力學,法規,趨勢分析

  • 市場力學
  • 成長促進因素
  • 成長阻礙因素
  • 市場機會
  • 影響分析
  • 技術的進步
  • PEST分析
  • 顯微鏡比較
  • 波特的五力分析
  • COVID-19大流行的影響分析

第4章 COVID-19大流行的影響

第5章 市場分析: 各產品類型

  • 簡介
  • 市場佔有率分析:2019年和2027年
  • 與前一年同期比較成長率分析:2017年-2027年
  • 市場區隔趨勢
    • Cyclosporine
    • 口服類固醇
    • 人工眼淚
    • Omega補充品
    • 眼藥袋
    • 其他

第6章 市場分析: 各流通管道

  • 簡介
  • 市場佔有率分析:2019年和2027年
  • 與前一年同期比較成長率分析:2017年-2027年
  • 市場區隔趨勢
    • 醫院藥局
    • 零售藥局
    • 超級市場/大賣場
    • 其他商店
    • 線上藥局

第7章 市場分析: 各地區

  • 簡介
  • 市場佔有率分析:2019年和2027年
  • 與前一年同期比較成長率分析:2017年-2027年
  • 市場區隔趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 非洲
    • 北非
    • 中非
    • 南非
  • 中東
    • GCC
    • 以色列
    • 其他

第8章 競爭情形

  • 企業簡介
    • Allergan
    • Novartis AG
    • Bausch Health Companies,Inc.
    • Johnson and Johnson Vision Care Inc.
    • I-Med Pharma Inc
    • Santen Pharmaceuticals Co. Ltd.
    • AFT Pharmaceuticals
    • Novaliq GmBH
    • Otsuka Pharmaceutical Co. Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.

第9章

目錄

Title:
Dry Eye Syndrome Treatment Market, by Product Type (Cyclosporine, Corticosteroids, Lifitegrast, Ocular Lubricant, Punctal Plug, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Supermarket/ Hypermarket, Other Stores, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Dry eye syndrome (DES) is also known as keratisis sicca and keratoconjunctivitis sicca. Patients suffering from DES show damage to the ocular surface, instability in the tear film, and visual disturbance. Tear film covers the ocular surface which is made up of three intertwined layers, a superficial lipid layer produced by meibomian glands assist in reducing tear evaporation and uniform tear spreading, middle thick aqueous layer produced from lacrimal glands, and the innermost hydrophilic mucin layer produced from goblet cells of conjunctiva and epithelium of ocular surface.

Market Dynamics

New dry eye therapies are introduced in the market with several new medications in the pipeline seeking approval. Strong product pipeline offers great market growth opportunity as approval of numerous pipeline products is expected to drive the market growth during the forecast period. In August 2018, Sun Pharma received approval for Cequa (cyclosporine ophthalmic solution) 0.09% from the U.S. FDA. The drug is indicated to increase tear production in patients with dry eye disease. Cequa is the only approved cyclosporine product that incorporates a nanomicellar technology and allows better penetration of the active molecule into the ocular tissues. Moreover, in January 2018, Shire plc. received FDA approval for Xiidra (lifitegrast ophthalmic solution 5%), a twice-daily eye drop solution for dry eye disease in adults in Canada. The drug was initially approved by the U.S. FDA in 2016. Thus, product approvals are expected to provide an opportunity for manufacturers to introduce novel therapies in the market.

Key features of the study:

  • This report provides in-depth analysis of the dry eye syndrome treatment market, market size (US$ Million) and compound annual growth rate (CAGR (%)) for the forecast period, 2020-2027, considering 2019 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global dry eye syndrome treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study are Allergan Plc., Novartis AG, Bausch Health Companies, Inc., Johnson and Johnson Vision Care Inc., I-Med Pharma Inc., Santen Pharmaceuticals Co. Ltd., AFT Pharmaceuticals, Novaliq GmBH, Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future product launches, end user upgrades, market expansion, and marketing tactics
  • The global dry eye syndrome treatment market report caters to various stakeholders in this industry, including investors, drug/product manufacturers, distributors and suppliers for dry eye Syndrome Treatment Market, research and consulting firms, new entrants, and financial analysts
  • Various strategy matrices used in analyzing the dry eye syndrome treatment market would provide stakeholders vital inputs to make strategic decisions accordingly.

Detailed Segmentation:

  • Global Dry Eye Syndrome Treatment Market, By Product Type :
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
  • Global Dry Eye Syndrome Treatment Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
  • Global Dry Eye Syndrome Treatment Market, By Region:
    • North America
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • U.S.
    • Canada
    • Europe
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
    • Latin America
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Product Type:
    • Cyclosporine
    • Oral Corticosteroid
    • Artificial Tears
    • Omega Supplements
    • Punctual Bags
    • Others
      • By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Supermarket/ Hypermarket
    • Other Stores
    • Online Pharmacies
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
  • Allergan
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
  • Bausch Health Companies, Inc.
  • Johnson and Johnson Vision Care Inc.
  • I-Med Pharma Inc
  • Santen Pharmaceuticals Co. Ltd.
  • AFT Pharmaceuticals
  • Novaliq GmBH
  • Otsuka Pharmaceutical Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Technological Evolution
  • PEST Analysis
  • Microscope Comparison
  • Porters Analysis
  • COVID-19 Impact Analysis

4. Global Dry Eye Syndrome Treatment Market, Impact of COVID-19 Pandemic

  • COVID19 Impact
  • Economic Impact
  • Demand and Supply Impact Analysis

5. Global Dry Eye Syndrome Treatment Market, By Product Type, 2020-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Cyclosporine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Oral Corticosteroid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Artificial Tears
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Omega Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Punctual Bags
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

6. Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2020-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Supermarket/ Hypermarket
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Other Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016-2027, (US$ Bn)

7. Global Dry Eye Syndrome Treatment Market, By Region, 2020-2027 (US$ Bn)

  • Introduction
  • Market Share Analysis, By Region, 2020 and 2027 (%)
  • Y-o-Y Growth Analysis, For Region, 2017-2027
  • North America
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • U.S.
  • Canada
  • Europe
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Africa
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country/Region, 2016-2027 (US$ Bn)
  • Central Africa
  • South Africa
  • North Africa
  • Middle East
  • Market Size and Forecast, By Product Type, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Distribution Channel, 2016-2027 (US$ Bn)
  • Market Size and Forecast, By Country, 2016-2027 (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East

8. Competitive Landscape

  • Company Profiles
  • Allergan
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bausch Health Companies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson and Johnson Vision Care Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • I-Med Pharma Inc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Santen Pharmaceuticals Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AFT Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novaliq GmBH
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Otsuka Pharmaceutical Co. Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

  • References
  • Research Methodology
  • About us and Sales Contact